Post Cluster-Randomized Controlled Trial: Longer-Term Efficacy of a Bystander Program to Reduce Violence Perpetration and Victimization in a Prospective Cohort

被引:1
|
作者
Coker, Ann L. [1 ]
Huang, Zhengyan [2 ]
Ding, Xue [3 ]
Brancato, Candace J. [4 ]
Clear, Emily R. [5 ]
Bush, Heather M. [6 ]
Follingstad, Diane R. [7 ]
机构
[1] Univ Kentucky, Coll Med, Ctr Res Violence Women, Dept Obstet & Gynecol, Suite 418,2365 Harrodsburg Rd, Lexington, KY 40504 USA
[2] Everest Clin Res Corp, Markham, ON, Canada
[3] Bristol Myers Squibb, Seattle, WA USA
[4] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA
[5] Univ Kentucky, Coll Publ Hlth, Dept Hlth Management & Policy, Lexington, KY 40536 USA
[6] Univ Kentucky, Coll Publ Hlth, Ctr Res Violence Women, Dept Biostat, Lexington, KY USA
[7] Univ Kentucky, Coll Med, Lexington, KY USA
关键词
Cohort; Young adult; Sexual violence; Dating violence; Prevention; Bystander intervention; ASSAULT RESISTANCE PROGRAM; INTERVENTION; PREVENTION; DIFFUSION; SECONDARY;
D O I
10.1007/s10896-024-00718-8
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
PurposeIn this cohort analyses, we sought to estimate the longer-term efficacy of a high-school based bystander intervention to reduce gender-based violence (GBV) into young adulthood.MethodsSeniors were recruited from 23 of 26 high schools that participated in the original RCT (2010-2014) designed to test the effectiveness of a bystander intervention to reduce GBV. Of 3,389 high school seniors who completed an electronic survey in their last term, 1,986 complete at least one annual follow up survey through 2018 (58.6% retention). Receipt of bystander training was defined based on (1) the high school the participant attended ('as randomized' in the original RCT) and (2) participants' report of additional bystander training received after high school ('as reported'). The primary GBV outcomes were sexual violence perpetration and victimization rates (%) for the past 12 months.ResultsOnly at the final follow up were significant reductions in sexual violence perpetration (SVP) noted for the 'as randomized' analyses. Self-reported SVP rates were 38% lower (adjusted rate ratio = 0.62; 95% Confidence Interval (CI): 0.48-0.81) among 1,107 participants who had attended schools randomized to the bystander intervention (SVP = 2.1%: 95% CI; 1.6-2.9) relative to 877 participants who had attended control schools (SVP = 3.4%; 95% CI: 3.0-3.9). Receipt of additional bystander training after high school was not associated with lower rates of any GBV form when compared with participants receiving no bystander training in or after high school.ConclusionsBystander training was not consistently associated with longer-term reductions in GBV perpetration nor victimization in this prospective cohort study based on a large school-based RCT.
引用
收藏
页数:15
相关论文
共 42 条
  • [31] Short-Term Secondary Effects of a School-Based Drug Prevention Program: Cluster-Randomized Controlled Trial of the Brazilian Version of DARE’s Keepin’ it REAL
    Juliana Y. Valente
    Zila M. Sanchez
    Prevention Science, 2022, 23 : 10 - 23
  • [32] Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in Mali compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)
    Suzanne Van Hulle
    Issaka Sagara
    Momar Mbodji
    Ghislain Ismael Nana
    Mamadou Coulibaly
    Alassane Dicko
    Mamady Kone
    Ismaila Thera
    Daman Sylla
    Mamadou Diango Traore
    Fang Liu
    John P. Grieco
    Nicole L. Achee
    Trials, 23
  • [33] Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in Mali compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)
    Van Hulle, Suzanne
    Sagara, Issaka
    Mbodji, Momar
    Nana, Ghislain Ismael
    Coulibaly, Mamadou
    Dicko, Alassane
    Kone, Mamady
    Thera, Ismaila
    Sylla, Daman
    Traore, Mamadou Diango
    Liu, Fang
    Grieco, John P.
    Achee, Nicole L.
    TRIALS, 2022, 23 (01)
  • [34] Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial
    Thaci, Diamant
    Vender, Ron
    de Rie, Menno A.
    Conrad, Curdin
    Pariser, David M.
    Strober, Bruce
    Vanvoorden, Veerle
    Wang, Maggie
    Madden, Cynthia
    de Cuyper, Dirk
    Kimball, Alexa B.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (01) : 22 - 31
  • [35] Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in western Kenya compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)
    Eric O. Ochomo
    John E. Gimnig
    Achuyt Bhattarai
    Aaron M. Samuels
    Simon Kariuki
    George Okello
    Bernard Abong’o
    Eunice A. Ouma
    Jackline Kosgei
    Stephen Munga
    Kiambo Njagi
    Wycliffe Odongo
    Fang Liu
    John P. Grieco
    Nicole L. Achee
    Trials, 23
  • [36] Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in western Kenya compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)
    Ochomo, Eric O.
    Gimnig, John E.
    Bhattarai, Achuyt
    Samuels, Aaron M.
    Kariuki, Simon
    Okello, George
    Abong'o, Bernard
    Ouma, Eunice A.
    Kosgei, Jackline
    Munga, Stephen
    Njagi, Kiambo
    Odongo, Wycliffe
    Liu, Fang
    Grieco, John P.
    Achee, Nicole L.
    TRIALS, 2022, 23 (01)
  • [37] The 18-month efficacy of an Intensive LifeStyle Modification Program (ILSM) to reduce type 2 diabetes risk among rural women: a cluster randomized controlled trial
    Qinyi Zhong
    Yao Chen
    Mengchun Luo
    Qian Lin
    Jianghong Tan
    Shuiyuan Xiao
    James Allen Willey
    Jyu-Lin Chen
    Robin Whittemore
    Jia Guo
    Globalization and Health, 19
  • [38] The 18-month efficacy of an Intensive LifeStyle Modification Program (ILSM) to reduce type 2 diabetes risk among rural women: a cluster randomized controlled trial
    Zhong, Qinyi
    Chen, Yao
    Luo, Mengchun
    Lin, Qian
    Tan, Jianghong
    Xiao, Shuiyuan
    Willey, James Allen
    Chen, Jyu-Lin
    Whittemore, Robin
    Guo, Jia
    GLOBALIZATION AND HEALTH, 2023, 19 (01)
  • [39] Facilitating Recovery of Daily Functioning in People With a Severe Mental Illness Who Need Longer-Term Intensive Psychiatric Services: Results From a Cluster Randomized Controlled Trial on Cognitive Adaptation Training Delivered by Nurses
    Stiekema, Annemarie P. M.
    van Dam, Michelle T.
    Bruggeman, Richard
    Redmeijer, Jeroen E.
    Swart, Marte
    Dethmers, Marian
    Rietberg, Kees
    Wekking, Ellie M.
    Velligan, Dawn, I
    Timmerman, Marieke E.
    Aleman, Andre
    Castelein, Stynke
    van Weeghel, Jaap
    Pijnenborg, Gerdina M. H.
    van der Meer, Lisette
    SCHIZOPHRENIA BULLETIN, 2020, 46 (05) : 1259 - 1268
  • [40] A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield™) against Aedes-borne virus infection among children ≥ 4–16 years of age in the Gampaha District, Sri Lanka: study protocol (the AEGIS program)
    Hasitha Tissera
    D. S. Anoja F. Dheerasinghe
    Neelika Malavige
    H. Asita de Silva
    Amy C. Morrison
    Thomas W. Scott
    Robert C. Reiner
    John P. Grieco
    Nicole L. Achee
    Trials, 24